Skin Cancer News and Research

Latest Skin Cancer News and Research

FDA approves Janssen Biotech's SIMPONI ARIATM for infusion for active rheumatoid arthritis

Janssen Biotech, Inc. announced today the U.S. Food and Drug Administration approval of SIMPONI ARIATM (golimumab) for infusion for the treatment of adults with moderately to severely active rheumatoid arthritis in combination with methotrexate.

19 Jul 2013

Recent advances put melanoma at the forefront of cancer research

A decade ago there was little doctors could do to help a patient with advanced-stage melanoma. Now it seems each week yields important new discoveries about the deadly skin cancer.

17 Jul 2013

Researchers obtain new knowledge about proteases that play role in cancer spread

Researchers from the University of Copenhagen and the National Institutes of Health have obtained ground-breaking new knowledge about proteases - important enzymes which, among other things, play a role in the development of cancer cells.

12 Jul 2013

Nerves play critical role in development and spread of prostate tumors, say researchers

Researchers at Albert Einstein College of Medicine of Yeshiva University have found that nerves play a critical role in both the development and spread of prostate tumors. Their findings, using both a mouse model and human prostate tissue, may lead to new ways to predict the aggressiveness of prostate cancer and to novel therapies for preventing and treating the disease. The study published online today in the July 12 edition of Science.

12 Jul 2013

New discoveries about skin cancer

We've heard the warning many times before: wear sunscreen or cover up before going out into the sun. It's an alert worth paying attention to; the American Cancer Society expects 460 new cases to be diagnosed in 2013 in New Mexico alone. Now Marianne Berwick, PhD, and her international team of melanoma researchers support these warnings with some interesting discoveries about skin cancer.

11 Jul 2013

RPCI scientists assess safety and efficacy of immunotherapy approach to treat advanced melanoma

A new clinical research study at Roswell Park Cancer Institute (RPCI) will assess the safety and efficacy of a novel immunotherapy approach to treating advanced melanoma. Developed at RPCI by Roswell Park researchers, the investigational vaccine shows promise for treating tumors in patients with stage III/stage IV melanoma, and perhaps as a future therapy for other solid-tumor cancers as well.

30 Jun 2013

Patients' medical follow-up after melanoma diagnosis should be lifelong, says study author

Recurrence of melanoma skin cancer 10 or more years after initial treatment is more common than previously thought, occurring in more than one in 20 patients. However, according to a new study, these patients tend to live longer after their cancer returns than patients whose melanoma recurs in the first three years.

28 Jun 2013

Physician offers helpful tips to a healthy summer

Summer is officially here, and for many, so is the threat of sunburn, bug bites and allergies. Deepti Shivakumar, MD, family practice at Gottlieb Memorial Hospital, offers some helpful tips to a healthy summer.

27 Jun 2013

University of Sheffield researchers show how human skin constantly regrows

We constantly grow new skin and slough off the old. Until now, scientists have never agreed on exactly how this works, but new research from the University of Sheffield may provide the answer.

27 Jun 2013

Encoded masks offer increased speed and efficiency in single-pixel THz imaging

The universe is awash in terahertz (THz) waves, as harmless as they are abundant. But unlike other regions of the electromagnetic spectrum, THz has proven to be extremely difficult to manipulate in order to capture novel images of objects and materials with which these light waves interact.

26 Jun 2013

Sentinel lymph node biopsy for early breast cancer: an interview with Prof. Gordon Wishart, Anglia Ruskin University

Our current method, which is recommended by the Association of Breast Surgeons in the UK, involves the use of injections of blue dye and radioisotope to identify the first node(s) under the arm (axilla) called the sentinel nodes.

25 Jun 2013

Texas passes legislation to prohibit minors under 18 from indoor tanning

Texas has joined California, Vermont, Oregon, and Nevada by passing legislation that prohibits minors under the age of 18 from indoor tanning. This announcement comes shortly after the U.S. Food and Drug Administration proposed stricter regulations on indoor tanning beds, as well as a strong recommendation against the use of tanning beds by minors under the age of 18.

18 Jun 2013

Non-invasive odor analysis: A valuable technique for early diagnosis of melanoma

According to new research from the Monell Center and collaborating institutions, odors from human skin cells can be used to identify melanoma, the deadliest form of skin cancer. In addition to detecting a unique odor signature associated with melanoma cells, the researchers also demonstrated that a nanotechnology-based sensor could reliably differentiate melanoma cells from normal skin cells.

14 Jun 2013

Tips for preventing skin cancer

Skin cancer is the most common form of cancer diagnosed in the United States, with one in five Americans expected to develop a form of skin cancer in their lifetime. Fortunately, there are simple steps people can take to reduce their skin cancer risk.

12 Jun 2013

Tumor suppressor p53 inactivation and restoration: an interview with Dr. Xin Lu, Ludwig Institute for Cancer Research

Before we talk about p53, it is important to understand why cancer cells are a problem for the body. Cancer cells multiply recklessly, refuse to die and blithely metastasize to set up shop in places where they don’t belong.

12 Jun 2013

Studies demonstrate that combined therapy could destroy drug-resistant cells within melanoma tumor

Advanced metastatic melanoma is a disease that has proven difficult to eradicate. Despite the success of melanoma-targeting drugs, tumors inevitably become drug resistant and return, more aggressive than before. In the current issue of the journal Cancer Cell, however, researchers at The Wistar Institute describe how they increase the effectiveness of anti-melanoma drugs by combining anticancer therapies with diabetes drugs.

12 Jun 2013

Connecticut passes law that bans minors from using indoor tanning devices

Connecticut has sent a strong message to young people that indoor tanning salons can be dangerous to their health by passing a law that bans minors under the age of 17 years old from using indoor tanning devices. The law is based on significant scientific evidence that links indoor tanning to increased risk of developing melanoma and other forms of skin cancer.

11 Jun 2013

Study: Solar radiation in Spain increased by 2.3% every decade

Solar radiation in Spain has increased by 2.3% every decade since the 1980s, according to a study by researchers from the University of Girona and the Federal Institute of Technology (ETH) in Zurich. This increase is linked to the decreased presence of clouds, which has increased the amount of direct radiation reaching us from the Sun.

7 Jun 2013

Ingenol mebutate drug does not offer added benefit over diclofenac/hyaluronic acid gel

The drug ingenol mebutate (trade name: Picato) has been approved in Germany since November 2012 as a gel for the treatment of certain forms of actinic keratosis in adults. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG) the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether this new drug offers an added benefit over diclofenac/hyaluronic acid gel. Such an added benefit cannot be derived from the dossier, however, as the drug manufacturer did not submit any relevant data: it did not cite any studies that directly compared ingenol mebutate with diclofenac/hyaluronic acid gel, and the method chosen by the manufacturer for an indirect comparison was unsuitable.

7 Jun 2013

Scientists develop first dual-action drug against melanoma skin cancer cells

Scientists are reporting development and successful lab tests on the first potential drug to pack a lethal one-two punch against melanoma skin cancer cells. Hit number one destroys cells in the main tumor, and the second hit blocks the spread of the cancer to other sites in the body, according to their report in the journal ACS Chemical Biology.

6 Jun 2013

Skin Cancer News and Research

Latest Skin Cancer News and Research

FDA approves Janssen Biotech's SIMPONI ARIATM for infusion for active rheumatoid arthritis

Recent advances put melanoma at the forefront of cancer research

Researchers obtain new knowledge about proteases that play role in cancer spread

Nerves play critical role in development and spread of prostate tumors, say researchers

New discoveries about skin cancer

RPCI scientists assess safety and efficacy of immunotherapy approach to treat advanced melanoma

Patients' medical follow-up after melanoma diagnosis should be lifelong, says study author

Physician offers helpful tips to a healthy summer

University of Sheffield researchers show how human skin constantly regrows

Encoded masks offer increased speed and efficiency in single-pixel THz imaging

Sentinel lymph node biopsy for early breast cancer: an interview with Prof. Gordon Wishart, Anglia Ruskin University

Texas passes legislation to prohibit minors under 18 from indoor tanning

Non-invasive odor analysis: A valuable technique for early diagnosis of melanoma

Tips for preventing skin cancer

Tumor suppressor p53 inactivation and restoration: an interview with Dr. Xin Lu, Ludwig Institute for Cancer Research

Studies demonstrate that combined therapy could destroy drug-resistant cells within melanoma tumor

Connecticut passes law that bans minors from using indoor tanning devices

Study: Solar radiation in Spain increased by 2.3% every decade

Ingenol mebutate drug does not offer added benefit over diclofenac/hyaluronic acid gel

Scientists develop first dual-action drug against melanoma skin cancer cells

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Skin Cancer News and Research

Latest Skin Cancer News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in